Overview
Profile
Experience
Kim & Chang (2018, 2021-Current)
Researcher, Bioinfra Life Science, Inc. (2018-2021)
Knobbe, Martens, Olson & Bear LLP (2015-2017)
Representative ActivitiesView All
Publications/Activities
- Patent-Eligible Subject Matter (South Korea), Practical Law Global, Thomson Reuters (Co-author, 2023)
- Inventive Step Standard of Korean Patent Law in Relation to Pharmaceutical Invention, 17(3) L. & Tech. 50 (2021)
- Determining Punitive Damages for Patent Infringement - Intentional Infringement and Statutory Factors Affecting Punitive Damages, 16(2) L. & Tech. 87 (2020)
- Artificial Intelligence and Patent-Eligible Subject Matter Under Korean Patent Law, 15(5) L. & Tech. 18 (2019)
- The Legal Battle Around CRISPR Gene-Editing Technology and Its Implications, 36 Biotech. L. Rep. 39 (2017)
- What SCOTUS's Refusal To Review Cases on Patent-Eligible Subject Means, MedCity News (January 2017)
- Ten Strategies for Aggressively Building a Patent Portfolio, Medical Device and Diagnostics Industry (MD+DI) (November 2016)
- The Defend Trade Secrets Act's Implications for Medtech, Medical Device and Diagnostic Industry (MD+DI) (June 2016)
- Draft Guideline for the Revised De Novo Classification Process, Harv. J.L. & Tech. Dig. (June 2016)
- Taxpayer Data Disclosure for Academic Use in South Korea, 79 Tax Notes Int'l 955 (2015) (Co-authored with Yunjung Song)
- Written Description Problems of the Monoclonal Antibody Patents after Centocor v. Abbott, Harv. J.L. & Tech. Dig. (March 2014)
Education
Graduate School of Law, Seoul National University (Completed Coursework, LL.D., 2021)
Harvard Law School (J.D., 2015)
Graduate School of Arts and Sciences, Harvard University (Ph.D. Candidate, Molecular Biology, 2013-2014)
Cornell University (B.S., Biological Engineering, summa cum laude, Banner Bearer, 2010)
Qualifications
Admitted to bar, California, 2016
Admitted to patent bar (limited recognition), U.S. Patent and Trademark Office, 2016
Languages
English and Korean
Insights
-
Newsletters
Grace Period Available for Divisional Even if Not Sought in Parent Application
2022.12.16 -
Newsletters
KIPO Adopts New ST.26 Standards for Sequence Listings in Patent Applications
2022.09.30 -
Newsletters
New Regulations Proposed for Companies in Strategic High-Tech Industries in Korea
2022.06.15 -
Newsletters
Korean IP Creation Continues to Increase Despite COVID-19
2022.06.15 -
Newsletters
The Supreme Court Clarifies the Limits of Application of Res Judicata in Patent Cases
2022.03.10 -
Newsletters
Key Issues Related to NFT (2) - General Overview of Copyright Issues Related to NFT
2021.12.22